FDA: Higher doses of Xeljanz increase blood clot, death risk in UC - Healio

FDA: Higher doses of Xeljanz increase blood clot, death risk in UC  Healio

The FDA on Friday issued a safety alert and approved new warnings for the 10-mg, twice-daily dosage of tofacitinib after a possible increased risk for pulmonary ...



Comments

Post a Comment

Popular posts from this blog

Celgene Corporation Announces POMALYST® Granted Breakthrough Therapy Designation from FDA for HIV-Positive and Negative Kaposi Sarcoma - Global Banking And Finance Review

Celgene Corporation Announces POMALYST® Granted Breakthrough Therapy Designation from FDA for HIV-Positive and Negative Kaposi Sarcoma    Global Banking And Finance Review Celgene Corporation (NASDAQ:CELG) today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to ...
Read more